Efficacy of the 6-month thrice-weekly regimen in the treatment of new sputum smear-positive pulmonary tuberculosis under clinical trial conditions

National Medical Journal of India

Volumn 25, Issue 4, 2012, Pages 196-200

  Rekha, V V Banu ^a   Rajaram, K ^a   Kripasankar, A S ^a   Parthasarathy, R ^a   Umapathy, K C ^a   Sheikh, I ^a   Selvakumar, N ^a   Victor, M ^a   Niruparani, C ^a   Sridhar, R ^b   Jawahar, M S ^a  

^a NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^b Government Stanley Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG EFFICACY; DRUG SAFETY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RETROSPECTIVE STUDY; SEIZURE; SPUTUM CULTURE; SPUTUM SMEAR; TOXIC HEPATITIS; TREATMENT DURATION;

ADULT; ANTITUBERCULAR AGENTS; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; ETHAMBUTOL; FEMALE; HUMANS; INTENTION TO TREAT ANALYSIS; ISONIAZID; MALE; PYRAZINAMIDE; RECURRENCE; RIFAMPIN; SPUTUM; TREATMENT OUTCOME; TUBERCULOSIS;

EID: 84872008675     PISSN: 0970258X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Chauhan LS, Agarwal SP. The Revised National Tuberculosis Control Programme. In: Chauhan LS, Agarwal SP (eds). Tuberculosis control in India. New Delhi:Directorate General of Health Services, Ministry of Health and Family Welfare, 2005:23-34.
2. Khatri GR. The Revised National Tuberculosis Control Programme: A status report on first 1,00,000 patients. Indian J Tuberc 1999;46:157-66.
3. Santha T, Garg R, Frieden TR, Chandrasekaran V, Subramani R, Gopi PG, et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberc Lung Dis 2002 6:780-8.
4. Vijay S, Balasangameshwara VH, Jegannatha PS, Saroja VN, Kumar P. Treatment outcome and two and a half years follow-up status of new smear positive patients treated under RNTCP. Indian J Tuberc 2004;51:199-208.
5. TB India 2011. RNTCP status report. New Delhi:Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare. Available at http://www.tbcindia.org (accessed on 27 Dec 2011).
6. Thomas A, Gopi PG, Santha T, Chandrasekaran V, Subramani R, Selvakumar N, et al. Predictors of relapse among pulmonary tuberculosis patients treated in a DOTS programme in South India. Int J Tuberc Lung Dis 2005;9:556-61.
7. Holst E, Mitchison DA, Radhakrishna S. Examination of smears for tubercle bacilli by fluorescence microscopy. Indian J Med Res 1959;47:495-9.
8. Kent PT, Kubica GP. Isolation procedures. In: Public health mycobacteriology: A guide for Level III laboratory. Atlanta, Georgia:US Department of Health and Human Services, Public Health Center for Disease Control Service; 1985:42-3.
9. Allen BW, Baker FJ. Mycobacteria: Isolation, identification and sensitivity testing. London:Butterworths; 1968.
10. Kubica GP. Differential identification of mycobacteria. VII. Key features for identification of clinically significant mycobacteria. Am Rev Respir Dis 1973;107: 9-21.
11. Canetti G, Fox W, Khomenko A, Mahler HT, Menon NK, Mitchison DA, et al. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969;41:21-43.
12. Santha T, Thomas A, Chandrasekaran V, Selvakumar N, Gopi PG, Subramani R, et al. Initial drug susceptibility profile of M. tuberculosis among patients under TB programme in South India. Int J Tuberc Lung Dis 2006;10:52-7.
13. Tuberculosis Research Centre, Indian Council of Medical Research, Chennai, India. Low rate of emergence of drug resistance in sputum positive patients treated with short course chemotherapy. Int J Tuberc Lung Dis 2001;5:40-5.
14. Mitchison DA. Treatment of tuberculosis: The Mitchell lecture 1979. J R Coll Physicians Lond 1980;14:91-9.
15. Fox W. Short course chemotherapy for pulmonary tuberculosis: Advanced medicine. London:Pitman, Saunders KB, 1983;19:307-26.
16. Hong Kong Chest Service/British Medical Research Council. Controlled trial of 4 three-times-weekly regimens and a daily regimen all given for 6 months for pulmonary tuberculosis. Second report: The results up to 24 months. Tubercle 1982;63:89-98.
17. Tuberculosis Research Centre, Indian Council of Medical Research, Chennai. Shortening short course chemotherapy: A randomised clinical trial for treatment of smear-positive pulmonary tuberculosis with regimens using ofloxacin in the intensive phase. Indian J Tuberc 2002;49:27-38.
18. Fox W, Ellard GA, Mitchison DA. Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications. Int J Tuberc Lung Dis 1999;3 (10 Suppl 2):S231-S279.
19. Mitchison DA. Basic mechanisms of chemotherapy. Chest 1979;76 (6 Suppl): 771-81.
20. Kivihya-Ndugga LE, van Cleeff MR, Githui WA, Nganga LW, Kibuga DK, Odhiambo JA, et al. A comprehensive comparison of Ziehl-Neelsen and fluorescence microscopy for the diagnosis of tuberculosis in a resource-poor urban setting. Int J Tuberc Lung Dis 2003;7:1163-71.
21. Ulukanligil M, Aslan G, Tasçi S. A comparative study on the different staining methods and number of specimens for the detection of acid fast bacilli. Mem Inst Oswaldo Cruz 2000;95:855-8.
22. Bisoi S, Sarkar A, Mallik S, Haldar A, Haldar D. A study on performance, response and outcome of treatment under RNTCP in a tuberculosis unit of Howrah District, West Bengal. Indian J Comm Med 2007;32:245-8.
23. Chandrasekaran V, Gopi PS, Subramani R, Thomas A, Jaggarajamma K, Narayanan PR. Default during the intensive phase of treatment under DOTS programme. Indian J Tuberc 2005;52:197-202.
24. Gopi PG, Subramani R, Santha T, Radhakrishnan S, Chandrasekaran V, Rajeswari R, et al. Performance of a DOTS programme: Administrative and technical challenges: A field report from a district in South India. Indian J Tuberc 2006;53:123-4.
25. Zhang LX, Tu DH, Enarson DA. The impact of directly-observed treatment on the epidemiology of tuberculosis in Beijing. Int J Tuberc Lung Dis 2000;4:904-10.
26. China Tuberculosis Control Collaboration. Results of directly observed short-course chemotherapy in 112,842 Chinese patients with smear-positive tuberculosis. Lancet 1996;347:358-62.
27. Menzies D, Benedetti A, Paydar A, Martin I, Royce S, Pai M, et al. Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: A systematic review and meta-analysis. PLoS Med 2009;6:e1000146. Epub 2009 Sep 15.